Monocyte-Chemoattractant Protein-1 Levels in Human Atherosclerotic Lesions Associate With Plaque Vulnerability.

Aged Biomarkers / blood Carotid Stenosis / blood Chemokine CCL2 / blood Cross-Sectional Studies Endarterectomy, Carotid / adverse effects Female Humans Longitudinal Studies Male Middle Aged Plaque, Atherosclerotic Predictive Value of Tests Risk Assessment Risk Factors Rupture, Spontaneous Stroke / etiology Time Factors
atherosclerosis carotid stenosis chemokines collagen macrophages

Journal

Arteriosclerosis, thrombosis, and vascular biology
ISSN: 1524-4636
Titre abrégé: Arterioscler Thromb Vasc Biol
Pays: United States
ID NLM: 9505803

Informations de publication

Date de publication:
06 2021
Historique:
pubmed: 9 4 2021
medline: 10 8 2021
entrez: 8 4 2021
Statut: ppublish

Résumé

[Figure: see text].

Identifiants

DOI: 10.1161/ATVBAHA.121.316091 PMID: 33827260
pubmed: 33827260
doi: 10.1161/ATVBAHA.121.316091
doi:

Substances chimiques

Biomarkers 0
CCL2 protein, human 0
Chemokine CCL2 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2038-2048

Auteurs

Marios K Georgakis (MK)

Institute for Stroke and Dementia Research, University Hospital, LMU Munich, Germany (M.K.G., Y.A., M.D.).

Sander W van der Laan (SW)

Laboratory of Experimental Cardiology, University Medical Center Utrecht, University of Utrecht, the Netherlands (S.W.v.d.L., S.C.A.d.J.).

Yaw Asare (Y)

Institute for Stroke and Dementia Research, University Hospital, LMU Munich, Germany (M.K.G., Y.A., M.D.).

Joost M Mekke (JM)

Department of Vascular Surgery, Division of Surgical Specialties (J.M.M., D.P.V.d.K., G.J.d.B.), University Medical Centre Utrecht, Utrecht University, the Netherlands.

Saskia Haitjema (S)

Center Diagnostic Laboratory, Division Laboratories and Pharmacy (S.H., A.H.S., G.P.), University Medical Centre Utrecht, Utrecht University, the Netherlands.

Arjan H Schoneveld (AH)

Center Diagnostic Laboratory, Division Laboratories and Pharmacy (S.H., A.H.S., G.P.), University Medical Centre Utrecht, Utrecht University, the Netherlands.

Saskia C A de Jager (SCA)

Laboratory of Experimental Cardiology, University Medical Center Utrecht, University of Utrecht, the Netherlands (S.W.v.d.L., S.C.A.d.J.).

Nick S Nurmohamed (NS)

Department of Vascular Medicine (N.S.N., E.S.G.S.), Amsterdam University Medical Centers (UMC), University of Amsterdam, the Netherlands.
Department of Cardiology (N.S.N.), Amsterdam University Medical Centers (UMC), University of Amsterdam, the Netherlands.

Jeffrey Kroon (J)

Department of Experimental Vascular Medicine, Amsterdam Cardiovascular Sciences (J.K.), Amsterdam University Medical Centers (UMC), University of Amsterdam, the Netherlands.

Erik S G Stroes (ESG)

Department of Vascular Medicine (N.S.N., E.S.G.S.), Amsterdam University Medical Centers (UMC), University of Amsterdam, the Netherlands.

Dominique P V de Kleijn (DPV)

Department of Vascular Surgery, Division of Surgical Specialties (J.M.M., D.P.V.d.K., G.J.d.B.), University Medical Centre Utrecht, Utrecht University, the Netherlands.

Gert J de Borst (GJ)

Department of Vascular Surgery, Division of Surgical Specialties (J.M.M., D.P.V.d.K., G.J.d.B.), University Medical Centre Utrecht, Utrecht University, the Netherlands.

Lars Maegdefessel (L)

Department for Vascular and Endovascular Surgery, Klinikum Rechts der Isar, Technical University Munich, Germany (L.M.).
German Center for Cardiovascular Research (DZHK partner site), Munich, Germany (L.M.).

Oliver Soehnlein (O)

Institute for Cardiovascular Prevention, Klinikum LMU Munich, Germany (O.S.).
German Center for Cardiovascular Research, Partner Site Munich Heart Alliance, Munich, Germany (O.S.).
Department of Physiology and Pharmacology, Karolinska Institute, Stockholm, Sweden (O.S.).
Institute for Experimental Pathology (ExPat), Center for Molecular Biology of Inflammation, University of Münster, Germany (O.S.).

Gerard Pasterkamp (G)

Center Diagnostic Laboratory, Division Laboratories and Pharmacy (S.H., A.H.S., G.P.), University Medical Centre Utrecht, Utrecht University, the Netherlands.

Martin Dichgans (M)

Institute for Stroke and Dementia Research, University Hospital, LMU Munich, Germany (M.K.G., Y.A., M.D.).
Munich Cluster for Systems Neurology (SyNergy), Germany (M.D.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Sujet âgé › Monocyte-Chemoattractant Protein-1 Levels in...
questionsmedicales.fr › Facteurs biologiques › Marqueurs biologiques › Monocyte-Chemoattractant Protein-1 Levels in...
questionsmedicales.fr › Maladies cardiovasculaires › Maladies vasculaires › Angiopathies intracrâniennes › Artériopathies carotidiennes › Sténose carotidienne › Monocyte-Chemoattractant Protein-1 Levels in...
questionsmedicales.fr › Facteurs biologiques › Protéines et peptides de signalisation intercellulaire › Cytokines › Chimiokines › Chimiokines CC › Protéines chimioattractives monocytaires › Chimiokine CCL2 › Monocyte-Chemoattractant Protein-1 Levels in...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études épidémiologiques › Études transversales › Monocyte-Chemoattractant Protein-1 Levels in...
questionsmedicales.fr › Procédures de chirurgie opératoire › Procédures de chirurgie cardiovasculaire › Procédures de chirurgie vasculaire › Endartériectomie › Endartériectomie carotidienne › Monocyte-Chemoattractant Protein-1 Levels in...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Monocyte-Chemoattractant Protein-1 Levels in...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études épidémiologiques › Études de cohortes › Études longitudinales › Monocyte-Chemoattractant Protein-1 Levels in...
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Adulte d'âge moyen › Monocyte-Chemoattractant Protein-1 Levels in...
questionsmedicales.fr › États, signes et symptômes pathologiques › États anatomopathologiques › Plaque d'athérosclérose › Monocyte-Chemoattractant Protein-1 Levels in...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Méthodologie en recherche épidémiologique › Valeur prédictive des tests › Monocyte-Chemoattractant Protein-1 Levels in...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Statistiques comme sujet › Probabilité › Risque › Appréciation des risques › Monocyte-Chemoattractant Protein-1 Levels in...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Statistiques comme sujet › Probabilité › Risque › Facteurs de risque › Monocyte-Chemoattractant Protein-1 Levels in...
questionsmedicales.fr › États, signes et symptômes pathologiques › États anatomopathologiques › Rupture spontanée › Monocyte-Chemoattractant Protein-1 Levels in...
questionsmedicales.fr › Maladies cardiovasculaires › Maladies vasculaires › Angiopathies intracrâniennes › Accident vasculaire cérébral › Monocyte-Chemoattractant Protein-1 Levels in...
questionsmedicales.fr › Phénomènes physiques › Temps › Facteurs temps › Monocyte-Chemoattractant Protein-1 Levels in...